531 related articles for article (PubMed ID: 16102783)
1. Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide.
Lewanowitsch T; Miller JH; Irvine RJ
Life Sci; 2006 Jan; 78(7):682-8. PubMed ID: 16102783
[TBL] [Abstract][Full Text] [Related]
2. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal.
Lewanowitsch T; Irvine RJ
Eur J Pharmacol; 2002 Jun; 445(1-2):61-7. PubMed ID: 12065195
[TBL] [Abstract][Full Text] [Related]
3. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
5. Methadone-induced respiratory depression in the neonatal guinea pig.
Nettleton RT; Ransom TA; Abraham SL; Nelson CS; Olsen GD
Pediatr Pulmonol; 2007 Dec; 42(12):1134-43. PubMed ID: 17968993
[TBL] [Abstract][Full Text] [Related]
6. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
[TBL] [Abstract][Full Text] [Related]
7. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
Rubovitch V; Pick CG; Sarne Y
Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
[TBL] [Abstract][Full Text] [Related]
11. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
[TBL] [Abstract][Full Text] [Related]
12. Morphine withdrawal-induced c-fos expression in the heart: a peripheral mechanism.
González-Cuello A; Milanés MV; Castells MT; Laorden ML
Eur J Pharmacol; 2004 Mar; 487(1-3):117-24. PubMed ID: 15033383
[TBL] [Abstract][Full Text] [Related]
13. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Negus SS
J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
[TBL] [Abstract][Full Text] [Related]
14. Increased elevated plus maze open-arm time in mice during naloxone-precipitated morphine withdrawal.
Hodgson SR; Hofford RS; Norris CJ; Eitan S
Behav Pharmacol; 2008 Dec; 19(8):805-11. PubMed ID: 19020415
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic pain on morphine-induced respiratory depression in mice.
Kamei J; Ohsawa M; Hayashi SS; Nakanishi Y
Neuroscience; 2011 Feb; 174():224-33. PubMed ID: 21081158
[TBL] [Abstract][Full Text] [Related]
16. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl depression of respiration: Comparison with heroin and morphine.
Hill R; Santhakumar R; Dewey W; Kelly E; Henderson G
Br J Pharmacol; 2020 Jan; 177(2):254-266. PubMed ID: 31499594
[TBL] [Abstract][Full Text] [Related]
18. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
[TBL] [Abstract][Full Text] [Related]
19. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans.
Donny EC; Walsh SL; Bigelow GE; Eissenberg T; Stitzer ML
Psychopharmacology (Berl); 2002 May; 161(2):202-12. PubMed ID: 11981600
[TBL] [Abstract][Full Text] [Related]
20. Naloxone pro-drug rescues morphine induced respiratory depression in Sprague-Dawley rats.
Wallisch M; El Rody NM; Huang B; Koop DR; Baker JR; Olsen GD
Respir Physiol Neurobiol; 2012 Jan; 180(1):52-60. PubMed ID: 22027217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
